Cargando…
Evodiamine inactivates NF-κB and potentiates the antitumor effects of gemcitabine on tongue cancer both in vitro and in vivo
OBJECTIVE: The aim of this study was to investigate whether evodiamine (EVO) could potentiate the antitumor activity of gemcitabine (GEM) in tongue cancer cells and determine its potential underlying mechanisms. MATERIALS AND METHODS: Human Tca8113 and CAL-27 tongue squamous carcinoma cell lines wer...
Autores principales: | Guo, Qi, Liu, Yanmei, Zhao, Jiayuan, Wang, Jing, Li, Yue, Pang, Yunqing, Chen, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312051/ https://www.ncbi.nlm.nih.gov/pubmed/30643424 http://dx.doi.org/10.2147/OTT.S181062 |
Ejemplares similares
-
Gene regulation analysis of the effects of evodiamine on tongue squamous cell carcinoma
por: Wu, Yuyan, et al.
Publicado: (2019) -
Inhibitory effects of evodiamine on zymosan-induced inflammation: inactivation of NF-κB by inhibiting IκBα phosphorylation
por: Fan, X, et al.
Publicado: (2014) -
Enhanced Antitumor Efficacy of Gemcitabine by Evodiamine on Pancreatic Cancer via Regulating PI3K/Akt Pathway
por: Wei, Wei-Tian, et al.
Publicado: (2011) -
Evaluation of the Cardiotoxicity of Evodiamine In Vitro and In Vivo
por: Yang, Weifeng, et al.
Publicado: (2017) -
Antitumor Effects of Evodiamine in Mice Model Experiments: A Systematic Review and Meta-Analysis
por: Yin, Cong, et al.
Publicado: (2021)